IBOTTA INC-CL A (IBTA) Fundamental Analysis & Valuation

NYSE:IBTA • US4510511060

Current stock price

28.98 USD
-0.43 (-1.46%)
At close:
28.35 USD
-0.63 (-2.17%)
After Hours:

This IBTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IBTA Profitability Analysis

1.1 Basic Checks

  • In the past year IBTA was profitable.
  • In the past year IBTA had a positive cash flow from operations.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • IBTA's Return On Assets of 0.68% is fine compared to the rest of the industry. IBTA outperforms 77.17% of its industry peers.
  • Looking at the Return On Equity, with a value of 1.24%, IBTA is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.49%, IBTA perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for IBTA is significantly above the industry average of 6.70%.
  • The 3 year average ROIC (13.82%) for IBTA is well above the current ROIC(0.49%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.68%
ROE 1.24%
ROIC 0.49%
ROA(3y)7.58%
ROA(5y)N/A
ROE(3y)50.92%
ROE(5y)N/A
ROIC(3y)13.82%
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 50 -50 100 150

1.3 Margins

  • IBTA has a Profit Margin of 1.04%. This is in the better half of the industry: IBTA outperforms 75.00% of its industry peers.
  • The Operating Margin of IBTA (0.57%) is comparable to the rest of the industry.
  • IBTA's Gross Margin of 79.25% is amongst the best of the industry. IBTA outperforms 94.57% of its industry peers.
  • In the last couple of years the Gross Margin of IBTA has remained more or less at the same level.
Industry RankSector Rank
OM 0.57%
PM (TTM) 1.04%
GM 79.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.49%
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IBTA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IBTA is still creating some value.
  • IBTA has less shares outstanding than it did 1 year ago.
  • There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.56 indicates that IBTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.56, IBTA belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
  • There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.56
ROIC/WACC0.05
WACC9.08%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • IBTA has a Current Ratio of 1.96. This is a normal value and indicates that IBTA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of IBTA (1.96) is better than 71.74% of its industry peers.
  • A Quick Ratio of 1.96 indicates that IBTA should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.96, IBTA is doing good in the industry, outperforming 73.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IBTA Growth Analysis

3.1 Past

  • IBTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.05%.
  • Looking at the last year, IBTA shows a decrease in Revenue. The Revenue has decreased by -6.77% in the last year.
  • The Revenue has been growing by 17.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.97%
Revenue 1Y (TTM)-6.77%
Revenue growth 3Y17.57%
Revenue growth 5YN/A
Sales Q2Q%-10.02%

3.2 Future

  • IBTA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.22% yearly.
  • IBTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.57% yearly.
EPS Next Y-497.32%
EPS Next 2Y-130.91%
EPS Next 3Y-9.22%
EPS Next 5YN/A
Revenue Next Year1.58%
Revenue Next 2Y5.2%
Revenue Next 3Y7.57%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. IBTA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 193.20, which means the current valuation is very expensive for IBTA.
  • IBTA's Price/Earnings ratio is a bit cheaper when compared to the industry. IBTA is cheaper than 64.13% of the companies in the same industry.
  • IBTA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.88.
  • IBTA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 193.2
Fwd PE N/A
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as IBTA.
  • Based on the Price/Free Cash Flow ratio, IBTA is valued a bit cheaper than 66.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.57
EV/EBITDA 51.51
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • IBTA's earnings are expected to decrease with -9.22% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-130.91%
EPS Next 3Y-9.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IBTA Dividend Analysis

5.1 Amount

  • No dividends for IBTA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IBTA Fundamentals: All Metrics, Ratios and Statistics

IBOTTA INC-CL A

NYSE:IBTA (3/27/2026, 8:24:49 PM)

After market: 28.35 -0.63 (-2.17%)

28.98

-0.43 (-1.46%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-25
Earnings (Next)05-18
Inst Owners53.23%
Inst Owner Change-17.21%
Ins Owners16.23%
Ins Owner Change8.99%
Market Cap705.66M
Revenue(TTM)342.39M
Net Income(TTM)3.58M
Analysts51.43
Price Target28.41 (-1.97%)
Short Float %42.37%
Short Ratio11.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)660.91%
Min EPS beat(2)-292.16%
Max EPS beat(2)1613.97%
EPS beat(4)2
Avg EPS beat(4)393.53%
Min EPS beat(4)-292.16%
Max EPS beat(4)1613.97%
EPS beat(8)4
Avg EPS beat(8)200.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.97%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)4.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-6.83%
Max Revenue beat(4)4.28%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.01%
EPS NQ rev (1m)-26.32%
EPS NQ rev (3m)-42.86%
EPS NY rev (1m)-51.11%
EPS NY rev (3m)-233.88%
Revenue NQ rev (1m)7.62%
Revenue NQ rev (3m)7.62%
Revenue NY rev (1m)6.15%
Revenue NY rev (3m)6.08%
Valuation
Industry RankSector Rank
PE 193.2
Fwd PE N/A
P/S 2.06
P/FCF 11.57
P/OCF 7.41
P/B 2.45
P/tB 2.45
EV/EBITDA 51.51
EPS(TTM)0.15
EY0.52%
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)2.5
FCFY8.64%
OCF(TTM)3.91
OCFY13.5%
SpS14.06
BVpS11.81
TBVpS11.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.31
Profitability
Industry RankSector Rank
ROA 0.68%
ROE 1.24%
ROCE 0.62%
ROIC 0.49%
ROICexc 1.18%
ROICexgc 1.18%
OM 0.57%
PM (TTM) 1.04%
GM 79.25%
FCFM 17.81%
ROA(3y)7.58%
ROA(5y)N/A
ROE(3y)50.92%
ROE(5y)N/A
ROIC(3y)13.82%
ROIC(5y)N/A
ROICexc(3y)31.21%
ROICexc(5y)N/A
ROICexgc(3y)31.49%
ROICexgc(5y)N/A
ROCE(3y)17.49%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.49%
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 412.3%
Cap/Sales 10.02%
Interest Coverage 7.93
Cash Conversion 926.88%
Profit Quality 1705.48%
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 2.56
F-Score6
WACC9.08%
ROIC/WACC0.05
Cap/Depr(3y)220.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.12%
Cap/Sales(5y)N/A
Profit Quality(3y)632.43%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.97%
EPS Next Y-497.32%
EPS Next 2Y-130.91%
EPS Next 3Y-9.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.77%
Revenue growth 3Y17.57%
Revenue growth 5YN/A
Sales Q2Q%-10.02%
Revenue Next Year1.58%
Revenue Next 2Y5.2%
Revenue Next 3Y7.57%
Revenue Next 5YN/A
EBIT growth 1Y-92.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1624.74%
EBIT Next 3Y212.58%
EBIT Next 5YN/A
FCF growth 1Y-42.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.81%
OCF growth 3YN/A
OCF growth 5YN/A

IBOTTA INC-CL A / IBTA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IBOTTA INC-CL A (IBTA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBTA.


Can you provide the valuation status for IBOTTA INC-CL A?

ChartMill assigns a valuation rating of 2 / 10 to IBOTTA INC-CL A (IBTA). This can be considered as Overvalued.


What is the profitability of IBTA stock?

IBOTTA INC-CL A (IBTA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of IBOTTA INC-CL A (IBTA) stock?

The Price/Earnings (PE) ratio for IBOTTA INC-CL A (IBTA) is 193.2 and the Price/Book (PB) ratio is 2.45.


Can you provide the financial health for IBTA stock?

The financial health rating of IBOTTA INC-CL A (IBTA) is 7 / 10.